Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors

Molecular Therapy

Volumn 2, Issue 1, 2000, Pages 16-25

  Hauser, Michael A ^a,d   Robinson, Ann ^a   Hartigan O'Connor, Dennis ^a   Williams Gregory, DeeAnn ^b   Buskin, Jean N ^b   Apone, Steve ^b   Kirk, Christopher J ^a   Hardy, Stephen ^c   Hauschka, Stephen D ^b   Chamberlain, Jeffrey S ^a,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenovirus; Dendritic cell; Muscle creatine kinase; Muscle specific; Muscular dystrophy

Indexed keywords

ADENOVIRIDAE; CUCUMBER MOSAIC VIRUS;

BETA GALACTOSIDASE; CREATINE KINASE;

ADENOVIRUS; ANIMAL; ARTICLE; BIOLOGICAL MODEL; C57BL MOUSE; CELL LINE; CYTOLOGY; DENDRITIC CELL; ENZYMOLOGY; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; LIVER; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; MOUSE; MUSCLE; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REGULATORY SEQUENCE; TIME; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BASE SEQUENCE; BETA-GALACTOSIDASE; CELL LINE; CREATINE KINASE; DENDRITIC CELLS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER; MICE; MICE, INBRED C57BL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUSCLES; MUTAGENESIS; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; TIME FACTORS; TRANSGENES;

EID: 0034218590     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0089     Document Type: Article

References (56)

1. Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., and Briand, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90: 626-630.
2. Xiao, X., Li, J., and Samulski, R. J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70: 8098-8108.
3. Xiao, X., Li, J., and Samulski, R. J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72: 2224-2232.
4. Welling, T. H., et al. (1996). Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb. Hum. Gene Ther. 7: 1795-1802.
5. Drazan, K. E., Hebebrand, D., Shaked, A., and Jones, N. F. (1997). Gene transfer into nerve and muscle by isolated limb perfusion or during replantation. J. Reconst. Microsurg. 13: 383-387.
6. Greelish, J. P., et al. (1999). Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat. Med. 5: 439-443.
7. Jooss, K., Yang, Y., Fisher, K. J., and Wilson, J. M. (1998). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72: 4212-4223.
8. Kumar-Singh, R., and Chamberlain, J. S. (1996). Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5: 913-921.
9. Clemens, P. R., et al. (1996). In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3: 965-972.
10. Hartigan-O'Connor, D., and Chamberlain, J. S. (1999). Progress toward gene therapy of Duchenne muscular dystrophy. Semin. Neurol. 19: 323-332.
11. Krasnykh, V. N., Mikheeva, G. V., Douglas, J. T., and Curiel, D. T. (1996). Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J. Virol. 70: 6839-6846.
12. Douglas, J. T., and Curiel, D. T. (1997). Strategies to accomplish targeted gene delivery to muscle cells employing tropism-modified adenoviral vectors. Neuromusc. Disord. 7: 284-298.
13. Wickham, T. J., Carrion, M. E., and Kovesdi, I. (1995). Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750-756.
14. Wickham, T. J., et al. (1997). Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71: 8221-8229.
15. Harms, J. S., and Splitter, G. A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC 1 promoter. Hum. Gene Ther. 6: 1291-1297.
16. Loser, P., Jennings, G. S., Strauss, M., and Sandig, V. (1998). Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFkappaB. J. Virol. 72: 180-190.
17. Sandig, V., Loser, P., Lieber, A., Kay, M. A., and Strauss, M. (1996). HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther. 3: 1002-1009.
18. Franz, W. M., Rothmann, T., Frey, N., and Katus, H. A. (1997). Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters. Cardiovasc. Res. 35: 560-566.
19. Dematteo, R. P., et al. (1997). Engineering tissue-specific expression of a recombinant adenovirus: Selective transgene transcription in the pancreas using the amylase promoter. J. Surg. Res. 72: 155-161.
20. Tanaka, T., et al. (1997). Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. Biochem. Biophys. Res. Commun. 231: 775-779.
21. Lan. K. H., et al. (1996). Tumor-specific gene expression in carcinoembryonic antigen-producing gastric cancer cells using adenovirus vectors. Gastroenterology 111: 1241-1251.
22. Kanai, F., et al. (1996). Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Hepatology 23: 1359-1368.
23. Bui, L. A., et al. (1997). In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. Hum. Gene Ther. 8: 2173-2182.
24. Sato, Y., et al. (1998). Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem. Biophys. Res. Commun. 244: 455-462.
25. Gotoh, A., et al. (1998). Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J. Urol. 160: 220-229.
26. Welle, S., Bhatt, K., and Thornton, C. A. (1999). Inventory of high-abundance mRNAs in skeletal muscle of normal men. Genome Res. 9: 506-513.
27. Amacher, S. L., Buskin, J. N., and Hauschka, S. D. (1993). Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell. Biol. 13: 2753-2764.
28. Donoviel, D. B., Shield, M. A., Buskin, J. N., Haugen, H. S., Clegg, C. H., and Hauschka, S. D. (1996). Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice. Mol. Cell. Biol. 16: 1649-1658.
29. Chamberlain, J. S., Jaynes, J. B., and Hauschka, S. D. (1985). Regulation of creatine kinase induction in differentiating mouse myoblasts. Mol. Cell Biol. 5: 484-492.
30. Jaynes, J. B., Chamberlain, J. S., Buskin, J. N., Johnson, J. E., and Hauschka, S. D. (1986). Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol. Cell. Biol. 6: 2855-2864.
31. Trask, R. V., Strauss, A. W., and Billadello, J. J. (1988). Developmental regulation and tissue-specific expression of the human muscle creatine kinase gene. J. Biol. Chem. 263: 17142-17149.
32. Cserjesi, P., Lilly, B., Bryson, L., Wang, Y., Sassoon, D. A., and Olson, E. N. (1992). MHox: A mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer. Development 115: 1087-1101.
33. Shield, M. A., Haugen, H. S., Clegg, C. H., and Hauschka, S. D. (1996). E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol. Cell. Biol. 16: 5058-5068.
34. Jaynes, J. B., Johnson, J. E., Buskin, J. N., Gartside, C. L., and Hauschka, S. D. (1988). The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol. 8: 62-70.
35. Sternberg, E. A., Spizz, G., Perry, W. M., Vizard, D., Weil, T., and Olson, E. N. (1988). Identification of upstream and intragenic regulatory elements that confer cell-type-restricted and differentiation-specific expression on the muscle creatine kinase gene. Mol. Cell. Biol. 8: 2896-2909.
36. Johnson, J. E., Wold, B. J., and Hauschka, S. D. (1989). Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell. Biol. 9: 3393-3399.
37. Cox, G. A., et al. (1993). Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364: 725-729.
38. Phelps, S. F., et al. (1995). Expression of full-length and truncated dystrophin minigenes in transgenic mdx mice. Hum. Mol. Genet. 4: 1251-1258.
39. Rafael, J. A., Cox, G. A., Corrado, K., Jung, D., Campbell, K. P., and Chamberlain, J. S. (1996). Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134: 93-102.
40. Shi, Q., Wang, Y., and Worton, R. (1997). Modulation of the specificity and activity of a cellular promoter in an adenoviral vector. Hum. Gene Ther. 8: 403-410.
41. Larochelle, N., et al. (1997). Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer. Gene Ther. 4: 465-472.
42. Boshart M., Weber, F., Jahn, G., Dorsch-Hasler, K., Fleckenstein, B., and Schaffner, W. (1985). A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41: 521-530.
43. Niwa, M., Rose, S. D., and Berget, S. M. (1990). In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 4: 1552-1559.
44. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M. L. (1997). Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71: 1842-1849.
45. Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gonczol, E., and Wilson, J. M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.
46. Neville, C., Rosenthal, N., McGrew, M., Bogdonova, N., and Hauschka, S. (1997). Skeletal muscle cultures. In Methods in Cell Biology. Vol. 52: Methods in Muscle Biology, pp. 85-116. Academic Press, San Diego.
47. Henthorn, P., Zervos, P., Raducha, M., Harris, H., and Kadesch, T. (1988). Expression of a human placental alkaline phosphatase gene in transfected cells: Use as a reporter for studies of gene expression. Proc. Natl. Acad. Sci. USA 85: 6342-6346.
48. Neville, C., Rosenthal, N., and Hauschka, S. (1997). DNA transfection of cultured muscle cells. In Methods in Cell Biology. Vol. 52: Methods in Muscle Biology, pp. 405-422. Academic Press, San Diego.
49. MacGregor, G. M., Nolan, G. P., Fiering, S., Roederer, M., and Herzenberg, L. A. (1991). Use of E. coli lacZ (β-galactosidase) as a reporter gene. In Methods in Molecular Biology. Vol. 7: Gene Transfer and Expression Protocols, pp. 217-225, Human Press, Clifton, NJ.
50. Chen, B., Shi, Y., Smith, J. D., Choi, D., Geiger, J. D., and Mule, J. J. (1998). The role of tumor necrosis factor alpha in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cells and its role in enhancing the quality of dendritic cell function in presenting soluble antigens to CD4+ T cells in vitro. Blood 91: 4652-4661.
51. Buskin, J. N., and Hauschka, S. D. (1989). Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene. Mol. Cell. Biol. 9: 2627-2640.
52. Lassar, A. B., et al. (1989). MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 58: 823-831.
53. Apone, S., and Hauschka, S. D. (1995). Muscle gene E-box control elements. Evidence for quantitatively different transcriptional activities and the binding of distinct regulatory factors. J. Biol. Chem. 270: 21420-21427.
54. Kass-Eisler, A., Falck-Pedersen, E., Elfenbein, D. H., Alvira, M., Buttrick, P. M., and Leinwand, L. A. (1994). The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1: 395-402.
55. Yang, Y., Haecker, S. E., Su, Q., and Wilson, J. M. (1996). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5: 1703-1712.
56. Fabre-Suver, C., and Hauschka, S. D. (1996). A novel site in the muscle creatine kinase enhancer is required for expression in skeletal but not cardiac muscle. J. Biol. Chem. 271: 4646-4652.